Bucks pharma firm completes $138M IPO

The company plans to use the bulk of the funds for the launch of its recently approved nasal polyps treatment.

Source: bizjournals.com Health Care:Physician Practices headlines - October 18, 2017 Category: American Health Authors: John George Source Type: news